Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors-Reference-Cited by-同舟云学术

Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors

Published:2019-05-27 Issue:7 Volume:68 Page:1121-1132
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Leick Katie M.^ORCID,Pinczewski Joel,Mauldin Ileana S.,Young Samuel J.,Deacon Donna H.,Woods Amber N.,Bosenberg Marcus W.,Engelhard Victor H.,Slingluff Craig L.

Funder

National Institutes of Health

Cancer Research Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-019-02345-5.pdf

Reference44 articles.

1. Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT, Patterson JW, Slingluff CL Jr (2012) Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res 72(5):1070. https://doi.org/10.1158/0008-5472.can-11-3218

2. Bogunovic D, O’Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, Lonardi S, Zavadil J, Osman I, Bhardwaj N (2009) Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci USA 106(48):20429. https://doi.org/10.1073/pnas.0905139106

3. Mihm MC Jr, Clemente CG, Cascinelli N (1996) Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74(1):43

4. Wu X, Li J, Connolly EM, Liao X, Ouyang J, Giobbie-Hurder A, Lawrence D, McDermott D, Murphy G, Zhou J, Piesche M, Dranoff G, Rodig S, Shipp M, Hodi FS (2017) Combined anti-VEGF and anti-CTLA-4 therapy elicits humoral immunity to Galectin-1 which is associated with favorable clinical outcomes. Cancer Immunol Res 5(6):446–454. https://doi.org/10.1158/2326-6066.cir-16-0385

5. Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, Xu Y, Pogoriler E, Terzulli SL, Kuk D, Panageas KS, Ritter G, Sznol M, Halaban R, Jungbluth AA, Allison JP, Old LJ, Wolchok JD, Gnjatic S (2011) Integrated NY-ESO-1 antibody and CD8 + T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A 108(40):16723–16728. https://doi.org/10.1073/pnas.1110814108

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models;Molecular Pharmaceutics;2023-03-07

2. Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges;Seminars in Cancer Biology;2022-11

3. Exosome transportation-mediated immunosuppression relief through cascade amplification for enhanced apoptotic body vaccination;Acta Biomaterialia;2022-11

4. Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma;Frontiers in Immunology;2022-05-12

5. Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment;iScience;2022-01